NCT05486637

Vocal Emotion Communication With Cochlear Implants

Perception and Production of Emotional Prosody With Cochlear Implants
Father Flanagan's Boys' Home·ClinicalTrials.gov·behavioralRecruiting
View on ClinicalTrials.gov
Study focus
Disease/Condition
Cochlear Hearing Loss
Drug/Device/Intervention
Perception of acoustic cues to emotion
Study type
Observational
Intervention type
behavioral
Sponsor & location
Primary sponsor
Father Flanagan's Boys' Home
Location
Tempe,Omaha, United States of America
Timeline & enrollment
Phase
N/A
Start date
Jul 01, 2022
End date
Jun 30, 2027
Enrollment
255 participants
Primary outcome

Vocal emotion recognition accuracy,Vocal emotion recognition sensitivity,Voice pitch (fundamental frequency) of vocal productions,Intensity of vocal productions,Duration of vocal productions,Identifiability of recorded speech emotions

Summary

Patients with hearing loss who use cochlear implants (CIs) show significant deficits and
 strong unexplained intersubject variability in their perception and production of spoken
 emotions in speech. This project will investigate the hypothesis that cue-weighting, or how
 patients utilize the different acoustic cues to emotion, accounts for significant variance in
 emotional communication with CIs. The results will focus on children with CIs, but parallel
 measures in postlingually deaf adults with CIs will be made, ensuring that results of these
 studies benefit social communication by CI patients across the lifespan by informing the
 development of technological innovations and improved clinical protocols.

ICD-10 classifications
Other hearing lossOther specified hearing lossOtotoxic hearing lossHearing loss, unspecifiedSudden idiopathic hearing loss
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT05486637
Type
Non-Device Trial
About this record

Access comprehensive clinical trial information for NCT05486637 through Pure Global AI's free database. This phase not specified trial is sponsored by Father Flanagan's Boys' Home and is currently Recruiting. The study focuses on Cochlear Hearing Loss. Target enrollment is 255 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.